Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2019. Module: SNOMED CT Netherlands NRC maintained module (core metadata concept)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Is a | Tumor destruction (procedure) | true | Inferred relationship | Some | ||
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Using substance (attribute) | Lutetium-177 (substance) | true | Inferred relationship | Some | 1 | |
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Is a | chirurgische verrichting voor klinische bevinding en/of aandoening | false | Inferred relationship | Some | ||
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Direct morphology | Neoplasm, metastatic | true | Inferred relationship | Some | 1 | |
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Method | Radioactive destruction | true | Inferred relationship | Some | 1 | |
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Is a | Radionuclide therapy | true | Inferred relationship | Some | ||
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Has focus | primair maligne neoplasma van prostaat met metastase in bot | false | Inferred relationship | Some | 2 | |
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Has intent | Therapeutic | false | Inferred relationship | Some | 3 | |
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Using energy (attribute) | Radiation | false | Inferred relationship | Some | 3 | |
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Has focus | Metastatic malignant neoplasm to bone | false | Inferred relationship | Some | 2 | |
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Is a | Nuclear medicine study of systems | true | Inferred relationship | Some | ||
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Is a | Destruction of lesion by anatomic site | true | Inferred relationship | Some | ||
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Is a | Destructive procedure by organ system | true | Inferred relationship | Some | ||
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Is a | Nuclear medicine study by site | true | Inferred relationship | Some | ||
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Is a | Operation on bone | true | Inferred relationship | Some | ||
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Is a | Destructive procedure of musculoskeletal system | true | Inferred relationship | Some | ||
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Procedure site - Direct (attribute) | Bone structure | true | Inferred relationship | Some | 1 | |
| Radionuclide therapy for primary malignant neoplasm of prostate metastatic to bone using lutetium-177 prostate specific membrane antigen (procedure) | Using energy (attribute) | Radiation | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR